182 related articles for article (PubMed ID: 19251278)
1. Re: Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies: R. Abouassaly, N. Tan, A. Moussa and J. S. Jones J Urol 2008; 180: 911-914.
Feldstein MS; Hentz JG
J Urol; 2009 Apr; 181(4):1960-1; author reply 1961. PubMed ID: 19251278
[No Abstract] [Full Text] [Related]
2. Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies.
Abouassaly R; Tan N; Moussa A; Jones JS
J Urol; 2008 Sep; 180(3):911-4; discussion 914. PubMed ID: 18635220
[TBL] [Abstract][Full Text] [Related]
3. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy").
Montironi R; Scattoni V; Mazzucchelli R; Lopez-Beltran A; Bostwick DG; Montorsi F
Eur Urol; 2006 Oct; 50(4):666-74. PubMed ID: 16930809
[TBL] [Abstract][Full Text] [Related]
4. Re: A multi-institutional evaluation of active surveillance for low risk prostate cancer. S. E. Eggener, A. Mueller, R. K. Berglund, R. Ayyathurai, C. Soloway, M. S. Soloway, R. Abouassaly, E. A. Klein, S. J. Jones, C. Zappavigna, L. Goldenberg, P. T. Scardino, J. A. Eastham and B. Guillonneau J Urol 2009; 181: 1635-1641.
Ayres BE; Bott SR; Barber NJ; Langley SE; Montgomery BS
J Urol; 2010 Sep; 184(3):1223-4; author reply 1224. PubMed ID: 20655069
[No Abstract] [Full Text] [Related]
5. Re: Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J. S. Jones, A. Patel, L. Schoenfield, J. C. Rabets, C. D. Zippe and C. Magi-Galluzzi. J Urol, 175: 485-488, 2006.
Inman BA; Myers RP
J Urol; 2006 Sep; 176(3):1252-3; author reply 1253. PubMed ID: 16890738
[No Abstract] [Full Text] [Related]
6. Re: Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance K. Fujika, P. Landis, B. K. McNeil and C. P. Pavlovich J Urol 2009; 182: 2664-2669.
Atan A; Tuncel A
J Urol; 2010 Jun; 183(6):2471-2. PubMed ID: 20416896
[No Abstract] [Full Text] [Related]
7. Saturation biopsy for detecting and characterizing prostate cancer.
Jones JS
BJU Int; 2007 Jun; 99(6):1340-4. PubMed ID: 17428241
[No Abstract] [Full Text] [Related]
8. Re: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. K. Eichler, S. Hempel, J. Wilby, L. Myers, L. M. Bachmann and J. Kleijnen, J Urol, 175: 1605-1612, 2006.
Eskicorapci SY; Tuncay L
J Urol; 2006 Dec; 176(6 Pt 1):2745; author reply 2745-6. PubMed ID: 17085209
[No Abstract] [Full Text] [Related]
9. Re: Smaller prostate size predicts high grade prostate cancer at final pathology. M. R. Newton, S. Phillips, S. S. Chang, P. E. Clark, M. S. Cookson, R. Davis, J. H. Fowke, S. D. Herrell, R. Baumgartner, R. Chan, V. Mishra, J. D. Blume, J. A. Smith, Jr. and D. A. Barocas. J Urol 2010; 184: 930-937.
Calışkan S
J Urol; 2011 Apr; 185(4):1537-8; author reply 1538. PubMed ID: 21349547
[No Abstract] [Full Text] [Related]
10. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction.
Bott S; Langley S; Hindley R; Montgomery B
BJU Int; 2009 Mar; 103(5):701. PubMed ID: 19226428
[No Abstract] [Full Text] [Related]
11. Re: The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy: C. De Nunzio, A. Trucchi, R. Miano, A. Stoppacciaro, H. Fattahi, A. Cicione and A. Tubaro J Urol 2009; 181: 1069-1075.
Brimo F; Vollmer RT; Bismar TA
J Urol; 2009 Oct; 182(4):1653; author reply 1653-4. PubMed ID: 19683763
[No Abstract] [Full Text] [Related]
12. Re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur urol 2007;52:1663-9.
Boscolo-Berto R; Galfano A; Iafrate M
Eur Urol; 2008 Aug; 54(2):469-70; author reply 471. PubMed ID: 18299171
[No Abstract] [Full Text] [Related]
13. Prostate carcinoma II: prognostic factors in prostate needle biopsies.
Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Mikuz G; Algaba F; Boccon-Gibod L
BJU Int; 2006 Mar; 97(3):492-7. PubMed ID: 16469014
[No Abstract] [Full Text] [Related]
14. Re: The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy I. M. Thompson, C. M. Tangen, D. P. Ankerst, C. Chi, M. S. Lucia, P. Goodman, H. Parnes and C. A. Coltman, Jr. J Urol 2008; 180: 544-547.
Atmaca AF; Balbay MD
J Urol; 2009 May; 181(5):2387-8. PubMed ID: 19303084
[No Abstract] [Full Text] [Related]
15. [Therapeutic control by cytology in conservative treatment of carcinoma of the prostate].
Nagel R; Leistenschneider W
Arch Esp Urol; 1981; 34(5):347-58. PubMed ID: 7332369
[No Abstract] [Full Text] [Related]
16. A prospective randomised trial of extended core prostate biopsy protocols utilizing 12 versus 15 cores.
Rochester MA; Griffin S; Chappell B; McLoughlin J
Urol Int; 2009; 83(2):155-9. PubMed ID: 19752609
[TBL] [Abstract][Full Text] [Related]
17. Re: The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J. Feliciano, E. Teper, M. Ferrandino, R. J. Macchia, W. Blank, I. Grunberger and I. Colon J Urol 2008; 179: 952-955.
Ng CF; Chan SY
J Urol; 2008 Oct; 180(4):1570-1; author reply 1571. PubMed ID: 18718610
[No Abstract] [Full Text] [Related]
18. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.
Stamatiou K; Alevizos A; Mariolis A; Sofras F
J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735
[No Abstract] [Full Text] [Related]
19. Paraganglion of the prostate gland: an uncommon mimic of prostate cancer in needle biopsies.
Howarth SM; Griffiths DF; Varma M
Histopathology; 2005 Jul; 47(1):114-5. PubMed ID: 15982332
[No Abstract] [Full Text] [Related]
20. Re: The 20-core prostate biopsy protocol--a new gold standard?: V. Ravery, S. Dominique, X. Panhard, M. Toublanc, L. Boccon-Gibod and L. Boccon-Gibod. J Urol 2008; 179: 504-507.
Serefoglu EC; Ozdemir AT; Balbay MD
J Urol; 2008 Nov; 180(5):2256-7. PubMed ID: 18804806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
